1438. Uptake of 13-Valent Pneumococcal Conjugate Vaccine in High-Risk Adults Aged 19–64 Years: A Kaplan–Meier Approach

por Vietri, Jeffrey, Emir, Birol, Harnett, James, Chilson, Erica
Publicado 2018

Uptake of 13-Valent Pneumococcal Conjugate Vaccine among US Adults Aged 19 to 64 Years with Immunocompromising Conditions

por Vietri, Jeffrey, Harnett, James, Emir, Birol, Chilson, Erica
Publicado 2019

The relative burden of community-acquired pneumonia hospitalizations in older adults: a retrospective observational study in the United States

por Brown, Joshua D., Harnett, James, Chambers, Richard, Sato, Reiko
Publicado 2018

Evaluation of Real-World Experience with Tofacitinib Compared with Adalimumab, Etanercept, and Abatacept in RA Patients with 1 Previous Biologic DMARD: Data from a U.S. Administrat...

por Harnett, James, Gerber, Robert, Gruben, David, Koenig, Andrew S., Chen, Connie
Publicado 2016

Primary Nonadherence, Associated Clinical Outcomes, and Health Care Resource Use Among Patients with Rheumatoid Arthritis Prescribed Treatment with Injectable Biologic Disease-Modi...

por Harnett, James, Wiederkehr, Daniel, Gerber, Robert, Gruben, David, Bourret, Jeffrey, Koenig, Andrew
Publicado 2016

Impaired Quality of Life, Work, and Activities Among Adults with Clostridium difficile Infection: A Multinational Survey

por Heinrich, Kirstin, Harnett, James, Vietri, Jeffrey, Chambers, Richard, Yu, Holly, Zilberberg, Marya
Publicado 2018

Real-World Treatment Patterns and Costs for Patients with Renal Cell Carcinoma Initiating Treatment with Sunitinib and Pazopanib

por MacLean, Elizabeth, Mardekian, Jack, Cisar, Laura A., Hoang, Caroline J., Harnett, James
Publicado 2016

Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes

por Morrato, Elaine H., Newcomer, John W., Kamat, Siddhesh, Baser, Onur, Harnett, James, Cuffel, Brian
Publicado 2009

Use of electronic health records for early detection of high-cost, low back pain patients

por Maeng, Daniel D, Stewart, Walter F, Yan, Xiaowei, Boscarino, Joseph A, Mardekian, Jack, Harnett, James, Von Korff, Michael R
Publicado 2015

Adherence to Varenicline and Associated Smoking Cessation in a Community-Based Patient Setting

por Liberman, Joshua N., Lichtenfeld, Marc J., Galaznik, Aaron, Mastey, Vera, Harnett, James, Zou, Kelly H., Leader, Joseph B., Kirchner, H. Lester
Publicado 2013

Characterizing the Shifting Real-World Treatment Landscape by PD-L1 Testing Status and Expression Level in Advanced Non-Small Cell Lung Cancer

por Ge, Wenzhen, Wu, Ning, Quek, Ruben G. W., Liu, Jinjie, Pouliot, Jean-Francois, Dietz, Hilary, Jalbert, Jessica J., Harnett, James, Antonia, Scott J.
Publicado 2022

Machine learning models for identifying predictors of clinical outcomes with first-line immune checkpoint inhibitor therapy in advanced non-small cell lung cancer

por Li, Ying, Brendel, Matthew, Wu, Ning, Ge, Wenzhen, Zhang, Hao, Rietschel, Petra, Quek, Ruben G. W., Pouliot, Jean-Francois, Wang, Fei, Harnett, James
Publicado 2022

Real-World Outcomes and Prognostic Factors Among Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expression Treated with Immune Checkpoint Inhibitors as First-Line...

por Ge, Wenzhen, Wu, Ning, Jalbert, Jessica J, Quek, Ruben G W, Liu, Jinjie, Rietschel, Petra, Pouliot, Jean-Francois, Harnett, James, Hsu, Melinda Laine, Feliciano, Josephine L
Publicado 2022

PB2133: TRIAL IN PROGRESS: LINKER-MM3, A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF LINVOSELTAMAB VERSUS ELOTUZUMAB, POMALIDOMIDE, AND DEXAMETHASONE (EPD) IN RELAPSED/REFRACTORY MULT...

por Weisel, Katja, Hungria, Vania, Quach, Hang, Yoon, Sung-Soo, Rodríguez-Otero, Paula, Kroog, Glenn, Sinha, Arijit, Boyapati, Anita, Lyon, Charlotte, Lorenc, Karen Rodriguez, Inocencio, Timothy, Harnett, James, Chi, Lei, Moore, Vygngley, Voorhees, Peter
Publicado 2023

Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid...

por Cohen, Stanley B., Greenberg, Jeffrey D., Harnett, James, Madsen, Ann, Smith, Timothy W., Gruben, David, Zhang, Richard, Lukic, Tatjana, Woolcott, John, Dandreo, Kimberly J., Litman, Heather J., Blachley, Taylor, Lenihan, Anne, Chen, Connie, Rivas, Jose L., Dougados, Maxime
Publicado 2020

Patient‐reported outcomes with cemiplimab monotherapy for first‐line treatment of advanced non–small cell lung cancer with PD‐L1 of ≥50%: The EMPOWER‐Lung 1 study

por Gümüş, Mahmut, Chen, Chieh‐I, Ivanescu, Cristina, Kilickap, Saadettin, Bondarenko, Igor, Özgüroğlu, Mustafa, Gogishvili, Miranda, Turk, Haci M., Cicin, Irfan, Harnett, James, Mastey, Vera, Naumann, Ulrike, Reaney, Matthew, Konidaris, Gerasimos, Sasane, Medha, Brady, Keri J. S., Li, Siyu, Gullo, Giuseppe, Rietschel, Petra, Sezer, Ahmet
Publicado 2022

PB2357: TRIAL IN PROGRESS: OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH SYSTEMIC THERAPY FROM REAL-WORLD EXPERIENCE (ORCHID)

por Thieblemont, Catherine, MA, Qiufei, Hampp, Christian, Harnett, James, Sobel, Rachel E, Jalbert, Jessica J, Quek, Ruben Gw, Wei, Wenhui, Wu, Ning, Mastey, Vera, Wang, Joy, Bajwa, Anit, Maissenhaelter, Benedikt, van Gils, Chantal, Aggarwal, Shivani, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Bachy, Emmanuel, Damaj, Gandhi Laurent
Publicado 2023

PB2281: TRIAL IN PROGRESS: FOLLICULAR LYMPHOMA OUTCOMES IN RELAPSED/REFRACTORY PATIENTS TREATED WITH SYSTEMIC THERAPY IN A REAL-WORLD ASSESSMENT (FLORA)

por Damaj, Gandhi Laurent, Bachy, Emmanuel, MA, Qiufei, Hampp, Christian, Harnett, James, Sobel, Rachel E, Jalbert, Jessica J, Quek, Ruben Gw, Wei, Wenhui, Wu, Ning, Mastey, Vera, Wang, Joy, Bajwa, Anit, Maissenhaelter, Benedikt, van Gils, Chantal, Aggarwal, Shivani, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Thieblemont, Catherine
Publicado 2023